04/06/2016 - 11:21am

Lupin on Wednesday announced the appointment of Dr. Kurt Nielsen as president of Lupin-Somerset.

04/06/2016 - 10:53am
Lupin received final approval for Zolpidem Sublingual Tablets from the United States Food & Drug Administration earlier, as well as final clearance from the FTC with 180 days of exclusivity.
 
04/06/2016 - 10:35am

In connection with the termination of the merger agreement, Pfizer has agreed to pay Allergan $150 million for reimbursement of expenses associated with the transaction.

04/05/2016 - 12:29pm

Global Citizen is reporting that GlaxoSmithKline will be granting licenses to generics manufacturers in lower middle-income countries in a move aimed at increasing access to medicine in low-income countries. The company announced the changes at the end of March, noting that rather than attempting to enforce its patents, it would move to a licensing model, charging a small fee to generics manufacturers. (Global Citizen)

04/05/2016 - 10:51am

The accreditation program evaluated CVS Specialty based on such organizational standards as pharmacy care, pharmacy operations and specialty drug and patient management, as well as   the company’s customer service, communications and disclosure standards. 

04/05/2016 - 10:38am

The partnership is aimed at accelerating several of CutisPharma's products in development toward FDA approval. 

04/05/2016 - 10:25am
Diplomat will be dispensing Eli Lilly and Co.’s recently approved plaque psoriasis treatment as part of a limited-distribution network. 
04/05/2016 - 10:14am
ANI Pharmaceuticals on Tuesday announced the Food and Drug Administration approval for one new generic and the launch of another. 
04/05/2016 - 9:21am

Descovy has a similar antiviral efficacy to Gilead’s Viread (tenofovir disoproxil fumarate), but contains one-tenth the dose of tenofovir as Viread, the company said.